A transitional business strategy for Muslim-majority biopharmaceutical markets

Samsudin, Nurhusna and Hashim, Yumi Zuhanis Has-Yun and Jamaludin, Mohammad Aizat and Mahamad Maifiah, Mohd Hafidz (2026) A transitional business strategy for Muslim-majority biopharmaceutical markets. In: The 4th International Conference on Islamic Business Bangkok (ICIBB) 2026, 16-17 July 2026, Bangkok, Thailand.

PDF - Published Version Restricted to Registered users only Download (4MB) | Request a copy

Abstract

The growth of the halal pharmaceutical and biopharmaceutical sectors has raised new expectations for vaccine manufacturers serving Muslim-majority and halal-sensitive markets. Much of the current discussion on halal vaccines still centres on post-production assurance such as ingredient review, supplier declarations, residual impurity assessment, and certification readiness. These measures remain important, especially for vaccines that are already in use. However, they should be viewed as a transitional response rather than the final goal of the halal biopharmaceutical industry. This paper discusses that Muslim-majority countries need to move, step by step, from evidence-based halal assurance towards halal-built-in vaccine platforms. In such platforms, halal requirements are considered from the beginning, including host cell selection, raw material sourcing, upstream processing, purification, formulation, documentation, and supply chain governance. Using a conceptual review approach, the paper brings together literature on halal vaccine certification, Muslim consumer trust, vaccine production and purification stage, quality-by-design, and vaccine market development. It proposes phases of transitional business framework, current halal assurance for existing vaccines, halal risk reduction in established manufacturing platforms, animal-component-free bioprocessing, halal-built-in host cell and platform development, and commercialisation for Muslim-majority biopharmaceutical markets. The paper contributes to Islamic business scholarship by reframing halal vaccine assurance not simply as a compliance exercise but as a strategic bridge towards halal vaccine authority, high-value halal biopharmaceutical innovation, and stronger participation of Muslim countries in global vaccine manufacturing.

Item Type:	Proceeding Paper (Other)
Uncontrolled Keywords:	halal vaccine, halal pharmaceuticals, halal-built-in platform, Muslim markets, halal assurance.
Subjects:	BPH Islamic Economics > BPH117.3 Halal Pharmaceutical
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	International Institute for Halal Research and Training (INHART)
Depositing User:	Dr Nurhusna Samsudin
Date Deposited:	27 Oct 2026 17:48
Last Update:	27 Oct 2026 17:48
Queue Number:	2026-10-Q5831
URI:	http://irep.iium.edu.my/id/eprint/132251
Indexed In:	UNSPECIFIED

Actions (login required)

View Item